Relationship between atorvastatin dose and the harm caused by torcetrapib

Development of the cholesteryl ester transfer protein (CETP) inhibitor, torcetrapib, was halted after the ILLUMINATE trial revealed an increase in both all-cause mortality (ACM) and major cardiovascular events (MCVEs) associated with its use. We now report that the harm caused by torcetrapib was con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barter, Philip J., Rye, Kerry-Anne, Beltangady, Mohan S., Ports, William C., Duggan, William T., Boekholdt, S. Matthijs, DeMicco, David A., Kastelein, John J. P., Shear, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Biochemistry and Molecular Biology 2012
Assuntos:
Patient-Oriented and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466012/
https://ncbi.nlm.nih.gov/pubmed/22941786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P026328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados